Clinical characteristics and outcomes of 144 critically ill children receiving therapeutic plasma exchange in a pediatric intensive care unit: a single-center retrospective study
- 1Pediatric Intensive Care Unit, Pediatric Center, Zhujiang Hospital, Southern Medical University , , ,
Abstract
Background: Therapeutic plasma exchange (TPE) is increasingly used in critically ill children, yet pediatric data remain scarce. This study aimed to characterize the clinical features, indications, complications, and outcomes of children receiving TPE in a pediatric intensive care unit (PICU).
Methods: We retrospectively enrolled 144 children who underwent TPE in the PICU of Zhujiang Hospital, Southern Medical University, between January 2017 and December 2021. Demographic data, diagnoses, TPE indications (categorized according to the 2019 American Society for Apheresis [ASFA] guidelines), complications, and outcomes were collected. Multivariate logistic regression was performed to identify risk factors for mortality.
Results: The 144 children (median age, 66 months; median Pediatric Risk of Mortality III score, 18) underwent 414 TPE sessions. The leading indications were neurological disorders (29.2%), liver diseases (19.4%), and hematologic disorders (16.7%); 57.6% of patients were treated for ASFA category III indications. The complication rate was 16.9% per session, with filter or circuit clotting the most frequent event (7.2%); all complications resolved after prompt management, and no treatment-related death occurred. Overall PICU mortality was 36.8%, highest in the liver disease group (60.7%) and lowest in the neurological disorder group (16.7%) (P = 0.012). Non-survivors had higher rates of multiple organ dysfunction syndrome (MODS), mechanical ventilation, and vasopressor use than survivors (all P < 0.001). Multivariate analysis identified MODS (odds ratio [OR] = 5.609, 95% confidence interval [CI]: 1.189-26.453) and vasopressor use (OR = 6.551, 95% CI: 1.310-32.768) as independent risk factors for mortality.
Conclusions: TPE is generally safe in critically ill children when performed in an experienced PICU. MODS and vasopressor requirement independently predicted death. Because no control group was included, treatment efficacy could not be evaluated; our conclusions are limited to the safety and clinical profile of TPE in this population.
Related
- Clinical Characteristics and Management of Pediatric Facial Wounds with Documented Infection or Delayed Presentation: A 25-Year Retrospective Case Series
- Clinical characteristics and prognosis of liver injury in patients receiving immune checkpoint inhibitor-based therapy: a real-world retrospective study
- [Clinical characteristics and in-hospital outcomes of patients receiving antithrombotic therapy in a cardiac intensive care unit in sub-Saharan Africa: a retrospective comparative study at the Cardiology Institute of Abidjan].
- Characteristics of patients receiving a prescription for adapted physical activity in Aubervilliers: a retrospective study
- Prevalence and Clinical Characteristics of Supernumerary Teeth in a Pediatric Clinical Population: A Retrospective Observational Study
BibTeX
@article{chen2026clinical,
title = {{Clinical characteristics and outcomes of 144 critically ill children receiving therapeutic plasma exchange in a pediatric intensive care unit: a single-center retrospective study}},
author = {Zhijiang Chen and Qiuju Wei and Jufang Liu and Cheng Zeng and Wei Zhao},
journal = {Frontiers in pediatrics},
year = {2026},
month = oct,
doi = {10.3389/fped.2026.1955886},
url = {https://europepmc.org/article/PMC/PMC13719583},
note = {CC BY},
}
RIS
TY - JOUR
TI - Clinical characteristics and outcomes of 144 critically ill children receiving therapeutic plasma exchange in a pediatric intensive care unit: a single-center retrospective study
AU - Zhijiang Chen
AU - Qiuju Wei
AU - Jufang Liu
AU - Cheng Zeng
AU - Wei Zhao
PY - 2026
DA - 2026/10/16
JO - Frontiers in pediatrics
DO - 10.3389/fped.2026.1955886
UR - https://europepmc.org/article/PMC/PMC13719583
AB - Background: Therapeutic plasma exchange (TPE) is increasingly used in critically ill children, yet pediatric data remain scarce. This study aimed to characterize the clinical features, indications, complications, and outcomes of children receiving TPE in a pediatric intensive care unit (PICU). Methods: We retrospectively enrolled 144 children who underwent TPE in the PICU of Zhujiang Hospital, Southern Medical University, between January 2017 and December 2021. Demographic data, diagnoses, TPE indications (categorized according to the 2019 American Society for Apheresis [ASFA] guidelines), complications, and outcomes were collected. Multivariate logistic regression was performed to identify risk factors for mortality. Results: The 144 children (median age, 66 months; median Pediatric Risk of Mortality III score, 18) underwent 414 TPE sessions. The leading indications were neurological disorders (29.2%), liver diseases (19.4%), and hematologic disorders (16.7%); 57.6% of patients were treated for ASFA category III indications. The complication rate was 16.9% per session, with filter or circuit clotting the most frequent event (7.2%); all complications resolved after prompt management, and no treatment-related death occurred. Overall PICU mortality was 36.8%, highest in the liver disease group (60.7%) and lowest in the neurological disorder group (16.7%) (P = 0.012). Non-survivors had higher rates of multiple organ dysfunction syndrome (MODS), mechanical ventilation, and vasopressor use than survivors (all P < 0.001). Multivariate analysis identified MODS (odds ratio [OR] = 5.609, 95% confidence interval [CI]: 1.189-26.453) and vasopressor use (OR = 6.551, 95% CI: 1.310-32.768) as independent risk factors for mortality. Conclusions: TPE is generally safe in critically ill children when performed in an experienced PICU. MODS and vasopressor requirement independently predicted death. Because no control group was included, treatment efficacy could not be evaluated; our conclusions are limited to the safety and clinical profile of TPE in this population.
SN - 2296-2360
ER -